SLAMF1 and autoimmune disease: We observed that, among all the populations of interest identified in the cohort 1, only B cells-expressing SLAMF1 (identified as SLEB1) were significantly increased in SLE compared to healthy and autoimmune diseases controls (Figure 5B).